200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 127759-89-1

127759-89-1

127759-89-1 | 6H-Purin-6-one, 2-amino-9-[(1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1,9-dihydro-

CAS No: 127759-89-1 Catalog No: AG000XDI MDL No:MFCD00870586

Product Description

Catalog Number:
AG000XDI
Chemical Name:
6H-Purin-6-one, 2-amino-9-[(1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1,9-dihydro-
CAS Number:
127759-89-1
Molecular Formula:
C11H15N5O3
Molecular Weight:
265.2685
MDL Number:
MFCD00870586
IUPAC Name:
2-amino-9-[(1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one
InChI:
InChI=1S/C11H15N5O3/c12-11-14-9-8(10(19)15-11)13-4-16(9)7-1-5(2-17)6(7)3-18/h4-7,17-18H,1-3H2,(H3,12,14,15,19)/t5-,6-,7-/m1/s1
InChI Key:
GWFOVSGRNGAGDL-FSDSQADBSA-N
SMILES:
OC[C@@H]1[C@@H](CO)C[C@H]1n1cnc2c1nc(N)[nH]c2=O
UNII:
8U5PYQ1R2E

Properties

Complexity:
415  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
0
Exact Mass:
265.117g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
265.273g/mol
Monoisotopic Mass:
265.117g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
126A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.9  

Literature

Title Journal
Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase. Biochemical and biophysical research communications 20040319
In vitro activity of potential anti-poxvirus agents. Antiviral research 20030101
A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. Journal of virology 20011001
Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents. Nucleosides, nucleotides & nucleic acids 20010101
Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Reviews in medical virology 20010101
Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection. Antiviral research 20001201
Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus. Antiviral research 20001101
In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas. Antiviral research 20001101
Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture. Journal of viral hepatitis 20000101
Guanosine analogues as anti-herpesvirus agents. Nucleosides, nucleotides & nucleic acids 20000101
Hydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogs. Antimicrobial agents and chemotherapy 19991201
Human cytomegalovirus: challenges, opportunities and new drug development. Antiviral chemistry & chemotherapy 19990901
Selective activity of various antiviral compounds against HHV-7 infection. Antiviral research 19990801
Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors. The Journal of clinical investigation 19990615
Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. Antimicrobial agents and chemotherapy 19970701
Susceptibility of human cytomegalovirus to two-drug combinations in vitro. Antiviral therapy 19961201
Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes. Antimicrobial agents and chemotherapy 19960401
Efficacy of BMS-180194 against experimental cytomegalovirus infections in immunocompromised mice. Antiviral research 19960301
Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral research 19951201
Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II. Chemical & pharmaceutical bulletin 19930301
Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell culture. Journal of medical virology 19911101
Antiviral activity of oxetanocins against varicella-zoster virus. Antimicrobial agents and chemotherapy 19910701
Synthesis and antiviral activity of enantiomeric forms of cyclobutyl nucleoside analogues. Journal of medicinal chemistry 19910401
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS. Journal of medicinal chemistry 19900501
Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro. Antimicrobial agents and chemotherapy 19900201
(+-)-(1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(+-)-BHCG or SQ 33,054]: a potent and selective inhibitor of herpesviruses. Antiviral research 19900101

Related Products

© 2019 Angene International Limited. All rights Reserved.